BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AdvanDx, Inc. 

400 TradeCenter
Suite 6990
Woburn  Massachusetts  01801  U.S.A.
Phone: 781-376-0009 Fax: 781-376-0111


SEARCH JOBS




Industry
Diagnostics






 Company News
Data From Thirteen Studies Highlighting AdvanDx, Inc.'s Infectious Disease Assays To Be Presented At The 114th General Meeting Of The American Society of Microbiology (ASM) 5/19/2014 6:21:09 AM
AdvanDx, Inc. Raises $12 Million To Accelerate The Expansion Of The Company's Molecular Diagnostic Product Offerings 4/8/2014 8:17:32 AM
AdvanDx, Inc. Announces FDA 510(K) Submission For Meca Xpressfish™ -- A New Method For Rapid Detection Of Methicillin-Resistant Staphylococcus Aureus (MRSA) From Positive Blood Cultures 3/18/2014 10:50:47 AM
AdvanDx, Inc. Adds Gram-Negative BC Assay to U.S. and E.U. Commercial Launch of QuickFISH(TM) - a 20 Min. Pathogen ID Platform for the Identification & Treatment of Sepsis 8/14/2013 9:24:39 AM
AdvanDx, Inc. Elects Former Roche Molecular Systems, Inc. (RHHBF.PK) CEO, Heiner Dreismann, Ph.D., to Its Board of Directors 3/27/2013 10:58:50 AM
AdvanDx, Inc. Adds Enterococcal Bacteremia Assay to U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID) Platform 1/10/2013 9:12:10 AM
AdvanDx, Inc. Announces U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID), the First Molecular Test to Enable Reporting of Pathogen Identification at the Time of Gram Stain Results From Positive Blood Cultures 9/10/2012 9:29:48 AM
AdvanDx, Inc. to Unveil QuickFISH™ (20 Min. Pathogen ID) at ECCMID 2012 3/15/2012 10:44:46 AM
AdvanDx, Inc. Release: New Study Shows PNA FISH(R) Test Reporting Dramatically Decreased Mortality and Hospital Costs for Patients with Bloodstream Infections 10/13/2011 10:55:05 AM
AdvanDx, Inc. Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R) 1/18/2011 6:34:29 AM
12345